Key result
Pterostilbene and its metabolite pinostilbene enhanced innate immune responses and inhibited EV-D68 replication in human respiratory cells, with EC50 values ranging from 1.336 to 4.997 µM.
Why the study?
Enterovirus D68 is a re-emerging respiratory pathogen linked to severe illness and acute flaccid myelitis, but effective vaccines or treatments remain scarce.
Does pterostilbene or pinostilbene reduce EV-D68 replication in human respiratory cells?
Does pterostilbene or pinostilbene reduce EV-D68 replication in human respiratory cells?
Effect estimate: EC50 1.336 to 4.997 µM
p-value: p=<0.05
Pterostilbene and pinostilbene enhance host innate immune recognition and suppress EV-D68 replication in vitro, representing a potential strategy for antiviral drug development.
Enterovirus D68 (EV-D68) is a globally re-emerging respiratory pathogen implicated in outbreaks of severe respiratory illnesses and associated with acute flaccid myelitis. However, effective vaccines or treatments for EV-D68 infections remain scarce. We demonstrated that the active constituent of blueberries, pterostilbene (Pte), and its major metabolite, pinostilbene (Pin), facilitated innate immune responses in EV-D68-infected human respiratory cells. Pte and Pin treatment clearly relieved EV-D68-triggered cytopathic effects. Importantly, both Pte and Pin disrupted viral RNA replication (EC50 rank from 1.336 to 4.997 µM) and infectious virion production in a dose-dependent manner, without cytotoxicity at virucidal concentrations. Pte- or Pin-treated respiratory cells did not show any influences on EV-D68 entry but showed substantially decreased viral RNA replication and protein synthesis. Finally, we showed that Pte and Pin broadly suppressed the replication capacity of circulating EV-D68 strains isolated from recent pandemics. In summary, our results suggest that Pte and its derivative, Pin, enhance host immune recognition of EV-D68 and suppress EV-D68 replication, which represents a promising strategy for antiviral drug development.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2023) studied Enterovirus D68 infection. Pterostilbene and pinostilbene vs. DMSO vehicle was evaluated on Viral RNA replication and infectious virion production (EC50) (EC50 1.336 to 4.997 µM, p=<0.05). Pterostilbene and its metabolite pinostilbene enhanced innate immune responses and inhibited EV-D68 replication in human respiratory cells, with EC50 values ranging from 1.336 to 4.997 µM.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: